Luo Jing, Liu Fei, Zhao Liang, Cheng Baochun, Hu Yangchun, Wang Xiaojian
Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, 218 Jixi, Hefei, Anhui, PR China.
Heliyon. 2023 Apr 19;9(5):e15568. doi: 10.1016/j.heliyon.2023.e15568. eCollection 2023 May.
This study is aimed to analyze the clinical outcomes of endovascular treatments for patients with intracranial vertebral artery dissecting aneurysms.
Clinical data of 32 patients with vertebral artery dissecting aneurysms who underwent endovascular procedures in the Department of Neurosurgery of our University from January 2016 to December 2019 were retrospectively analyzed. Nine cases were treated with endovascular occlusion; 23 cases received reconstructive treatment, including 20 cases of stent combined with coil embolization, and 3 cases of stent implantation. The angiography taken at 3-22 months after surgery was reviewed.
The endovascular treatments for all 32 cases were successful. Thirty-one cases had no postoperative complications during index hospital. Mid-term follow-up showed that: 27 cases (84%) had embolism; 5 cases (16%) had recurrence, of which 4 cases were treated again with endovascular procedures followed with no further complications and no recurrence, and 1 case received closely monitor but no reoperation. During an average follow-up of 10.5 months, except for one case that was self-discharged due to end-stage brainstem compression and respiratory failure, the rest of the patients were in stable conditions without bleeding or infarction.
Endovascular treatment of intracranial vertebral artery dissecting aneurysms is safe and effective. Recurrent vertebral artery dissecting aneurysms can be treated with endovascular reoperations with satisfactory outcomes.
本研究旨在分析颅内椎动脉夹层动脉瘤患者血管内治疗的临床结果。
回顾性分析2016年1月至2019年12月在我校神经外科接受血管内手术的32例椎动脉夹层动脉瘤患者的临床资料。9例行血管内闭塞治疗;23例行重建治疗,其中20例行支架联合弹簧圈栓塞,3例行支架植入。回顾术后3 - 22个月的血管造影。
32例患者血管内治疗均成功。31例患者在索引住院期间无术后并发症。中期随访显示:27例(84%)栓塞;5例(16%)复发,其中4例再次行血管内治疗,无进一步并发症且无复发,1例密切观察未再手术。平均随访10.5个月,除1例因终末期脑干受压和呼吸衰竭自动出院外,其余患者病情稳定,无出血或梗死。
颅内椎动脉夹层动脉瘤的血管内治疗安全有效。复发性椎动脉夹层动脉瘤可通过血管内再次手术治疗,效果满意。